Sign In

CSS Submit Button Rollover



General & Disorder-Specific Ethical & Clinical Considerations

NEW 2018
15 CE Credit Hours - Online Course - $129.00

Developed by Ofer Zur, Ph.D.

Course fulfills the licensing requirement of Psychopharmacology for CA LMFT applicants with out-of-state education.
Check with your state's licensing board.

This course was produced in collaboration between Taylor & Francis, PLC and the Zur Institute, Inc.
The Zur Institute, Inc. maintains responsibility for this continuing education program and its content.

Board Approvals for Psychologists, LMFTs, SWs, Counselors, & Nurses

Simply follow these steps:

1. Sign up securely online.
2. Read articles.

3. Submit evaluation & post-test.
4. Print your certificate.


To order this Course now
Order Course now, click here


General Course Description

PsychopharmacologyAs the trends toward medicalization and medication for mental disorders grow, psychologists, counselors, marriage and family therapists and social workers must expand their knowledge of psychopharmacology. When appropriate, they communicate with prescribing physicians. They also need to educate themselves regarding the pros and cons of using medications and to help clients, when necessary, communicate with their prescribing physicians. It is often helpful for the psychotherapist to communicate directly with the prescribing physician, especially with more vulnerable clients, such as the children, and the seriously mental ill, who are more likely to be over-diagnosed and have their meds inadequately monitored. Psychotherapists can do this effectively only if they, themselves, understand the advantages, pitfalls, interaction effects and other complexities of psychotropic medications.

This 15 CE credit hour intermediate level course consists of four parts. Part One presents shared decision-making models between patients and physicians and presents ethical and clinical guidelines concerning prescribing medications. Part Two discusses recent advances in medications for bipolar disorder, the ongoing controversy over the effectiveness of antidepressants for treating depression and the use of antidepressants for pregnant or lactating women. Part Three discusses ADHD medications for children and adolescents. The final section includes additional resources for further study.


Educational Objectives

    This course will teach the participant to:
  • Describe the CommonGround model of decision making about medications between physicians and patients
  • Describe a communication-centered epistemic model of shared decision-making between physicians and patients
  • Describe how prescribing patterns with vulnerable populations differ from prescribing patterns with other patients
  • Discuss patients' reactions and concerns about medications
  • Discuss the complex relationship between diagnosis and prescribing medications
  • Discuss whether the effectiveness of antidepressant medications is fundamentally a placebo effect
  • Describe the special considerations when prescribing medications for children and adolescents
  • Evaluate recent developments in medications for bipolar disorder
  • Discuss how antidepressants have altered depressed people's view of their self
  • Discuss considerations about prescribing antidepressants for pregnant or lactating women
  • Discuss the controversies surrounding increased diagnosis of ADHD
  • Describe mothers' views of ADHD medications
  • Describe the concept of the neurochemical self
  • Discuss the mechanisms of ADHD medications
  • Discuss the mechanisms of bipolar and antidepressant medications

Course Syllabus

  • Shared decision-making models between physicians and consumers regarding treatment and medications
    • CommonGround
    • Epistemic model
  • Issues concerning psychotropics for vulnerable populations
  • Over-prescribing
  • Inadequate monitoring
  • Prescribing for children, adolescents, the elderly and seriously mentally ill
  • Emerging medications for bipolar disorder
  • Controversies concerning antidepressants
    • Effectiveness versus placebo
    • Replacing traditional sense of self with neurochemical self
    • Prescribing for pregnant or lactating women
  • Medications for ADHD
    • Do we over-prescribe for ADHD?
    • Is ADHD over-diagnosed?
    • Mothers' views of ADHD medications for their children
    • Comparison of methylphenidate and atomoxetine
  • Additional resources for further study


To order this Course now
Order Course now, click here




Instructions for requesting accommodations for disabilities

Refund and Course Exchange Policies

Share This:

Follow Us On:     TwitterFacebookLinkedIn

Click here to receive clinical updates by e-mail.

Online Courses  -  Zur Institute on YouTubeYouTube
Live Workshops  -  Forensic & Expert Witness Services -  Consultations for Therapists
Private Practice Handbook  -  HIPAA Compliance Kit  -  Clinical Forms  -  CE Board Approvals  -  Discussions
Online Catalog -  Free Articles  -  Boundaries & Dual Relationships  -  General Public Resources  -  Seminars For General Public
Organizational Discounts  -  About Us  -  FAQ  -  Privacy, Disclaimer, Terms of Use, DMCA  -  ADA Policy & Grievance -  CV
Home -  Contact Us  -  Site Map

Ofer Zur, Ph.D., Director

321 S. Main St. #29, Sebastopol, CA 95472
Contact Zur Institute, Inc.

© 1997-2018 Zur Institute, Inc. All rights reserved. Privacy Statement, Disclaimer & Terms of Use.
Site design/maintenance by R&D Web